BYD Weighs Second European Assembly Plant as Recalls and a Chinese Slump Test Its Export Story

BYD plans up to three European assembly plants and a battery factory, with a second-site decision due by year-end as China profit drops 20.5%.

BYD is pressing ahead with a European manufacturing build-out that could eventually span three vehicle assembly plants plus a dedicated battery factory, according to Reuters, which cited the company's special adviser for Europe. A decision on where the second plant will go is expected before the end of the year, with Spain and France among the front-runners.

The expansion blueprint lands at an awkward moment. On Tuesday the stock added 1.4% to close at 9.16 euros, a modest bounce, yet it remains 14% lower since the start of the year and sits roughly 27% below its 52-week high of 12.49 euros. A separate reading put the previous session's close at 9.11 euros.

Szeged First, Then a Wider Footprint

Europe's current anchor is Hungary, where BYD has begun initial production steps in Szeged. Full-scale mass output there is slated for next year. Management has no intention of stopping at one site: a local manufacturing network is meant to give the group more room to react to shifting market demands while cutting transport distances.

The overseas push extends beyond passenger cars. Stella Li has said BYD plans to launch its first heavy truck in Europe next year, with local production of that vehicle type also envisioned over the longer term.

Those ambitions feed a strategy that leans ever harder on markets outside China. Management is targeting 1.9 million to 2.0 million deliveries abroad for full-year 2026, and two brokerages cited by Reuters have flagged a 2027 overseas goal above 2.5 million units.

A Home Market That No Longer Carries the Load

The contrast with China is stark. First-half 2026 revenue fell 7.1% to 344.8 billion yuan, while net profit dropped 20.5% to 12.3 billion yuan as a domestic price war chewed into manufacturer margins. August told the same story from opposite directions: home deliveries shrank 14.3% year on year, while exports surged 134.5% to a record 189,466 units.

That divergence is now the central question for anyone holding the stock. Can overseas profitability offset the earnings erosion at home? The bull case rests on a structural cost edge — Hyundai chief executive Jose Munoz told Reuters that Chinese EVs undercut established rivals by 30% to 40% in some markets. Brazil offers a snapshot of what that advantage can buy: 24,441 units in August, a 9.3% share, and a gap of roughly 3,000 vehicles to third-placed Chevrolet. In Europe, brand sales climbed 168% in the first half. A full ramp-up of production capacity after the switch to second-generation Blade batteries at the Xi'an plant is the operational piece that would need to fall into place.

Recalls Pile Up on Two Continents

Quality and compliance headaches are mounting in parallel. China's market regulator prompted a free repair campaign covering 183,211 Qin and Tang vehicles built between 2014 and 2022 over a faulty brake pedal component — described elsewhere as defective brake light switches. In Australia, 32,009 Shark 6 pickups are being recalled over the spare-wheel retention bracket, and the model has drawn scrutiny after researchers at Fortify Labs publicly demonstrated that they could reach basic vehicle functions without entering a password.

Trade barriers form the other arm of the squeeze. Washington already applies tariffs of about 100% on Chinese vehicle imports and is preparing software restrictions, while political resistance to low-cost imports is building in other regions. Should more target markets erect hurdles, the export-led growth model would lose momentum — and if defects multiply or trigger costly fixes, rising warranty and legal costs could erode the very margin advantage the overseas business depends on.

What to Watch Next

For the bulls, the bar is straightforward: monthly overseas deliveries holding above 180,000 units and an international margin staying above 20%. A break in either direction — whether from tighter trade restrictions or a deepening demand slump in China — would put the shares on course to slip below their yearly low. The next hard data point arrives with official September sales figures, which will show whether the recalls and the safety debate have already taken a bite out of order momentum abroad.